Treatment of Moderate to Severe Lateral Canthal Lines
Clinical trial NCT04249687 · COMPLETED
Trial details
- NCT number
- NCT04249687
- Sponsor
- Galderma R&D
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-10
- Primary completion
- 2020-09-25
- Enrollment
- 303
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.